Pharmaceutical Company Announces Preclinical Weight Loss Data
Promising Weight Loss Results, Comparable to Ozempic/Wegovy.
In a significant development for the pharmaceutical industry and those battling obesity, Vania Pharmaceuticals (VANI) recently announced encouraging preclinical weight loss data for# Vania Pharmaceuticals' NPM-115 Shows Promising Weight Loss Results, Comparable to Ozempic/Wegovy. $Vivani Medical(VANI.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
